Adrenergic α2 Receptor Antagonists
| Cat. No. | Product Name / Activity |
|---|---|
| 2341 | A 80426 mesylate |
| High affinity α2 antagonist. Also 5-HT uptake inhibitor | |
| 0928 | ARC 239 dihydrochloride |
| α2B antagonist | |
| 2937 | Atipamezole hydrochloride |
| Selective α2 antagonist | |
| 1133 | BRL 44408 maleate |
| Selective α2A antagonist | |
| 0792 | Efaroxan hydrochloride |
| α2 antagonist and I1, I3 ligand | |
| 0793 | Idazoxan hydrochloride |
| α2 antagonist. Also I2 ligand | |
| 0986 | Imiloxan hydrochloride |
| Highly selective α2B antagonist | |
| 2666 | JP 1302 dihydrochloride |
| Potent and selective α2C antagonist | |
| 2018 | Mirtazapine |
| α2 antagonist; also potent 5-HT2, 5-HT3 and H1 antagonist; antidepressant | |
| 0623 | Prazosin hydrochloride |
| α2B and α1 antagonist; also MT3 antagonist | |
| 0891 | Rauwolscine hydrochloride |
| α2 antagonist | |
| 0987 | RS 79948 hydrochloride |
| Potent and selective α2 antagonist | |
| 1324 | RX 821002 hydrochloride |
| Potent, selective α2D antagonist | |
| 4508 | S 32212 hydrochloride |
| α2-adrenoceptor antagonist; 5-HT2C inverse agonist | |
| 3866 | SKF 86466 hydrochloride |
| Potent and selective α2 antagonist | |
| 0631 | Spiroxatrine |
| Potent α2C antagonist | |
| 1127 | Yohimbine hydrochloride |
| Selective α2 antagonist |
Cardiovascular Research Product Guide
Our Cardiovascular Guide highlights over 250 products for cardiovascular research.
Request copyRequest PDF
Cardiovascular Life Science Poster
Written by J.J. Maguire and A.P. Davenport
Our Cardiovascular poster highlights the key G protein-coupled receptors involved in the regulation of vascular reactivity.
Request copyDownload PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFPain Life Science Poster
Written by Grant D. Nicol and Michael R. Vasko
Our Peripheral Sensitization poster gives a summary of the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF